tiprankstipranks
Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP

Titan Pharmaceuticals (TTNP) Stock Price & Analysis

780 Followers

TTNP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.00 - $16.90
Previous Close$9.29
Volume69.19K
Average Volume (3M)10.69K
Market Cap
$5.81M
Enterprise Value-$2.19M
Total Cash (Recent Filing)$8.10M
Total Debt (Recent Filing)$97.00K
Price to Earnings (P/E)-1.1
Beta1.07
Nov 11, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-8.26
Shares Outstanding781,503
10 Day Avg. Volume7,821
30 Day Avg. Volume10,686
Standard Deviation0.27
R-Squared0.07
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.74
Price to Sales (P/S)13.03
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-7.18
Enterprise Value/Gross Profit-3.93
Enterprise Value/Ebitda1.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

TTNP FAQ

What was Titan Pharmaceuticals’s price range in the past 12 months?
Titan Pharmaceuticals lowest stock price was $5.00 and its highest was $16.90 in the past 12 months.
    What is Titan Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Titan Pharmaceuticals’s upcoming earnings report date?
    Titan Pharmaceuticals’s upcoming earnings report date is Nov 11, 2024 which is in 228 days.
      How were Titan Pharmaceuticals’s earnings last quarter?
      Titan Pharmaceuticals released its earnings results on Nov 13, 2023. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.022.
        Is Titan Pharmaceuticals overvalued?
        According to Wall Street analysts Titan Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Titan Pharmaceuticals pay dividends?
          Titan Pharmaceuticals does not currently pay dividends.
          What is Titan Pharmaceuticals’s EPS estimate?
          Titan Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Titan Pharmaceuticals have?
          Titan Pharmaceuticals has 753,315 shares outstanding.
            What happened to Titan Pharmaceuticals’s price movement after its last earnings report?
            Titan Pharmaceuticals reported an EPS of -$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.032%.
              Which hedge fund is a major shareholder of Titan Pharmaceuticals?
              Currently, no hedge funds are holding shares in TTNP
              ---

              Titan Pharmaceuticals Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -39.28%
              12-Months-Change

              Fundamentals

              Return on Equity
              -105.55%
              Trailing 12-Months
              Asset Growth
              59.32%
              Trailing 12-Months

              Company Description

              Titan Pharmaceuticals

              Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Palatin Technologies
              Akebia Therapeutics
              Alnylam Pharma
              Akari Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis